The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 3273-3282

  Jilling, Tamas ^a,b   Simon, Dyan ^a   Lu, Jing ^a,b   Meng, Fan Jing ^b   Li, Dan ^b   Schy, Robert ^b   Thomson, Richard B ^a,b   Soliman, Antoine ^c   Arditi, Moshe ^c   Caplan, Michael S ^a,b,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d EVANSTON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; RNA; TOLL LIKE RECEPTOR 4;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MILK; ASPHYXIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EVALUATION; GENE EXPRESSION; HISTOLOGY; HOST PATHOGEN INTERACTION; INTESTINE CELL; INTESTINE EPITHELIUM; KLEBSIELLA PNEUMONIAE; LASER CAPTURE MICRODISSECTION; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ASSAY; RAT; REAL TIME ECHOGRAPHY; SCORING SYSTEM; SERRATIA MARCESCENS; STRESS; SUBMUCOSA;

EID: 33747807305     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.3273     Document Type: Article

References (53)

1. Reber, K. M., C. A. Nankervis, and P. T. Nowicki. 2002. Newborn intestinal circulation: physiology and pathophysiology. Clin. Perinatol. 29: 23-39.
2. Ford, H., S. Watkins, K. Reblock, and M. Rowe. 1997. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J. Pediatr. Surg. 32: 275-282.
3. Jilling, T., J. Lu, M. Jackson, and M. S. Caplan. 2004. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr. Res. 55: 622-629.
4. Nanthakumar, N. N., R. D. Fusunyan, I. Sanderson, and W. A. Walker. 2000. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc. Natl. Acad. Sci. USA 97: 6043-6048.
5. Mehall, J. R., C. A. Kite, D. A. Saltzman, T. Wallett, R. J. Jackson, and S. D. Smith. 2002. Prospective study of the incidence and complications of bacterial contamination of enteral feeding in neonates. J. Pediatr. Surg. 37: 1177-1182.
6. Walker, W. A. 1997. Breast milk and the prevention of neonatal and preterm gastrointestinal disease states: a new perspective. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 38: 321-331.
7. Caplan, M. S., E. Hedlund, L. Adler, and W. Hsueh. 1994. Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis. Pediatr. Pathol. 14: 1017-1028.
8. Rozenfeld, R. A., X. Liu, I. DePlaen, and W. Hsueh. 2001. Role of gut flora on intestinal group II phospholipase A2 activity and intestinal injury in shock. Am. J. Physiol. 281: G957-G963.
9. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
10. Naik, S., E. J. Kelly, L. Meijer, S. Pettersson, and I. R. Sanderson. 2001. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J. Pediat. Gastroenterol. Nutr. 32: 449-453.
11. Abreu, M. T., P. Vora, E. Faure, L. S. Thomas, E. T. Arnold, and M. Arditi. 2001. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167: 1609-1616.
12. Suzuki, M., T. Hisamatsu, and D. K. Podolsky. 2003. γ Interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect. Immun. 71: 3503-3511.
13. Melmed, G., L. S. Thomas, N. Lee, S. Y. Tesfay, K. Lukasek, K. S. Michelsen, Y. Zhou, B. Hu, M. Arditi, and M. T. Abreu. 2003. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 170: 1406-1415.
14. Fusunyan, R. D., N. N. Nanthakumar, M. E. Baldeon, and W. A. Walker. 2001. Evidence for an innate immune response in the immature human intestine: Toll-like receptors on fetal enterocytes. Pediatr. Res. 49: 589-593.
15. Chan, K. L., J. C. Ho, K. W. Chan, and P. K. Tam. 2002. A study of gut immunity to enterai endotoxin in rats of different ages: a possible cause for necrotizing enterocolitis. J. Pediatr. Surg. 37: 1435-1440.
16. Hooper, L. V., M. H. Wong, A. Thelin, L. Hansson, P. G. Falk, and J. I. Gordon. 2001. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291: 881-884.
17. Hooper, L. V., T. S. Stappenbeck, C. V. Hong, and J. I. Gordon. 2003. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4: 269-273.
18. Cario, E., and D. K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68: 7010-7017.
19. Toiyama, Y., T. Araki, S. Yoshiyama, J. Hiro, C. Miki, and M. Kusunoki. 2006. The expression patterns of Toll-like receptors in the ileal pouch mucosa of post-operative ulcerative colitis patients. Surg. Today 36: 287-290.
20. Ortega-Cava, C. F., S. Ishihara, M. A. Rumi, M. M. Aziz, H. Kazumori, T. Yuki, Y. Mishima, I. Moriyama, C. Kadota, N. Oshima, et al. 2006. Epithelial Toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis. Clin. Vaccine Immunol. 13: 132-138.
21. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
22. Mahler, M., I. J. Bristol, E. H. Leiter, A. E. Workman, E. H. Birkenmeier, C. O. Elson, and J. P. Sundberg. 1998. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am. J. Physiol. 274: G544-G551.
23. Stevceva, L., P. Pavli, G. Buffinton, A. Wozniak, and W. F. Doe. 1999. Dextran sodium sulphate-induced colitis activity varies with mouse strain but develops in lipopolysaccharide-unresponsive mice. J. Gastroenterol. Hepatol. 14: 54-60.
24. Kobayashi, M., M. N. Kweon, H. Kuwata, R. D. Schreiber, H. Kiyono, K. Takeda, and S. Akira. 2003. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Invest. 111: 1297-1308.
25. Fort, M. M., A. Mozaffarian, A. G. Stover, S. Correia Jda, D. A. Johnson, R. T. Crane, R. J. Ulevitch, D. H. Persing, H. Bielefeldt-Ohmann, P. Probst, et al. 2005. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J. Immunol. 174: 6416-6423.
26. Gazouli, M., C. Mantzaris, A. Kotsinas, P. Zacharatos, E. Papalambros, A. Archimandritis, J. Ikonomopoulos, and V. G. Gorgoulis. 2005. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J. Gastroenterol. 11: 681-685.
27. Torok, H. P., J. Glas, L. Tonenchi, T. Mussack, and C. Folwaczny. 2004. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin. Immunol. 112: 85-91.
28. 399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm. Bowel Dis. 11: 645-652.
29. Lakatos, P. L., L. Lakatos, F. Szalay, C. Willheim-Polli, C. Osterreicher, Z. Tulassay, T. Molnar, W. Reinisch, J. Papp, G. Mozsik, and P. Ferenci. 2005. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J. Gastroenterol. 11: 1489-1495.
30. 299Gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53: 987-992.
31. Braat, H., P. Stokkers, T. Hommes, D. Cohn, E. Vogels, I. Pronk, A. Spek, A. van Kampen, S. van Deventer, M. Peppelenbosch, and D. Hommes. 2005. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J. Mol. Med. 83: 601-609.
32. Pierik, M., G. De Hertogh, S. Vermeire, G. Van Assche, P. Van Eyken, S. Joossens, G. Claessens, R. Vlietinck, P. Rutgeerts, and K. Geboes. 2005. Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease. Gut 54: 223-227.
33. Fries, W., M. C. Renda, M. A. Lo Presti, A. Raso, A. Orlando, L. Oliva, M. R. Giofre, A. Maggio, A. Mattaliano, A. Macaluso, and M. Cottone. 2005. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am. J. Gastroenterol. 100: 2730-2736.
34. 299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. J. Clin. Lab. Anal. 16: 56-58.
35. Oostenbrug, L. E., J. P. Drenth, D. J. de Jong, I. M. Nolle, E. Oosterom, H. M. van Dullemen, K. van der Linde, G. J. te Meerman, G. van der Steege, J. H. Kleibeuker, and P. L. Jansen. 2005. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm. Bowel Dis. 11: 567-575.
36. Guo, Q. S., B. Xia, Y. Jiang, S. A. Morre, L. Cheng, J. Li, J. B. Crusius, and A. S. Pena. 2005. Polymorphisms of CD14 gene and TLR4 gene are not associated with ulcerative colitis in Chinese patients. Postgrad. Med. J. 81: 526-529.
37. Szebeni, B., R. Szekeres, K. Rusai, A. Vannay, G. Veres, A. Treszl, A. Arato, T. Tulassay, and B. Vasarhelyi. 2006. Genetic polymorphisms of CD14, toll-like receptor 4, and caspase-recruitment domain 15 are not associated with necrotizing enterocolitis in very low birth weight infants. J. Pediatr. Gastroenterol. Nutr. 42: 27-31.
38. Murray, P. R., E. J. Baron, and American Society for Microbiology. 2003. Manual of Clinical Microbiology. ASM Press, Washington, D.C.
39. Caplan, M. S., and T. Jilling. 2001. New concepts in necrotizing enterocolitis. Curr. Opin. Pediatr. 13: 111-115.
40. Claud, E. C., and W. A. Walker. 2001. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J. 15: 1398-1403.
41. Caplan, M. S., R. Miller-Catchpole, S. Kaup, T. Russell, M. Lickerman, M. Amer, Y. Xiao, and R. Thomson, Jr. 1999. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 117: 577-583.
42. Lin, H. C., B. H. Su, A. C. Chen, T. W. Lin, C. H. Tsai, T. F. Yeh, and W. Oh. 2005. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115: 1-4.
43. Bin-Nun, A., R. Bromiker, M. Wilschanski, M. Kaplan, B. Rudensky, M. Caplan, and C. Hammerman. 2005. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J. Pediatr. 147: 192-196.
44. Hentschel, J., I. de Veer, P. Gastmeier, H. Ruden, and M. Obladen. 1999. Neonatal nosocomial infection surveillance: incidences by site and a cluster of necrotizing enterocolitis. Infection 27: 234-238.
45. Cook, D. N., D. S. Pisetsky, and D. A. Schwartz. 2004. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5: 975-979.
46. Means, T. K., B. W. Jones, A. B. Schromm, B. A. Shurtleff, J. A. Smith, J. Keane, D. T. Golenbock, S. N. Vogel, and M. J. Fenton. 2001. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J. Immunol. 166: 4074-4082.
47. Abreu, M. T., E. T. Arnold, L. S. Thomas, R. Gonsky, Y. Zhou, B. Hu, and M. Arditi. 2002. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J. Biol. Chem. 277: 20431-20437.
48. Lotz, M., D. Gutle, S. Walther, S. Menard, C. Bogdan, and M. W. Hornef. 2006. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 203: 973-984.
49. Nadler, E. P., A. Stanford, X. R. Zhang, L. C. Schall, S. M. Alber, S. C. Watkins, and H. R. Ford. 2001. Intestinal cytokine gene expression in infants with acute necrotizing enterocolitis: interleukin-11 mRNA expression inversely correlates with extent of disease. J. Pediatr. Surg. 36: 1122-1129.
50. Holt, P. G., and C. A. Jones. 2000. The development of the immune system during pregnancy and early life. Allergy 55: 688-697.
51. Forchielli, M. L., and W. A. Walker. 2005. The role of gut-associated lymphoid tissues and mucosal defence. Br. J. Nutr. 93(Suppl. 1): S41-S48.
52. Harmsen, H. J., A. C. Wildeboer-Veloo, G. C. Raangs, A. A. Wagendorp, N. Klijn, J. G. Bindels, and G. W. Welling. 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 30: 61-67.
53. Krediet, T. G., N. van Lelyveld, D. C. Vijlbrief, H. A. Brouwers, W. L. Kramer, A. Fleer, and L. J. Gerards. 2003. Microbiological factors associated with neonatal necrotizing enterocolitis: protective effect of early antibiotic treatment. Acta Paediatr. 92: 1180-1182.